Rate My Professor Hazel Screen

Professor Hazel Screen is Head of the School of Engineering and Materials Science and Professor of Biomedical Engineering at Queen Mary University of London. She holds a BEng, MRes, and PhD from the University of London, and is a Chartered Engineer (CEng), Fellow of the Institution of Mechanical Engineers (FIMechE), and Member of the Institute of Physics and Engineering in Medicine (MIPEM). In her career, she has served as Drapers Teaching Fellow, contributing to student experience enhancements. She co-directs the Queen Mary University of London Centre for Predictive in vitro Models and the QMUL-Emulate Organs-on-Chips Centre, leads the EPSRC Centre for Doctoral Training in Next Generation Organ-Chip Technologies (COaCT), and is Director of the UK Organ-on-a-Chip Technologies Network. Professor Screen also acts as Treasurer and Trustee of the Association of Biomedical Engineers, Medical Engineers and Bioengineers (BioMedEng Association).

Her research specializations include tissue structure-function relationships and mechanobiology in load-bearing tissues such as tendons and heart valves, investigating injury mechanisms, age-related changes increasing injury risk, and prevention strategies. She develops predictive in vitro models using organ-chip technology to explore health and disease aetiology in musculoskeletal and cardiovascular systems, including effects on cell metabolism and routes to new treatments. Key publications encompass 'Tendon functional extracellular matrix' (Journal of Orthopaedic Research, 2015), 'The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: a systematic review' (The American Journal of Sports Medicine, 2015), 'An investigation into the effects of the hierarchical structure of tendon fascicles on micromechanical properties' (Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, 2004), 'Tendon structure and composition' (2016), and 'The role of the non-collagenous matrix in tendon function' (International Journal of Experimental Pathology, 2013). Through her leadership in national networks and centres, funded by UKRI and charities, she influences bioengineering policy and regulation.